Polarean Financial Statements From 2010 to 2025
| PLLWF Stock | USD 0 0.0007 41.18% |
Check Polarean Imaging financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Polarean Imaging's main balance sheet or income statement drivers, such as , as well as many indicators such as . Polarean financial statements analysis is a perfect complement when working with Polarean Imaging Valuation or Volatility modules.
Polarean |
Polarean Imaging plc Company Return On Equity Analysis
Polarean Imaging's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Polarean Imaging Return On Equity | -0.49 |
Most of Polarean Imaging's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Polarean Imaging plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Polarean Imaging plc has a Return On Equity of -0.4939. This is 97.94% lower than that of the Healthcare sector and 94.34% lower than that of the Medical Devices industry. The return on equity for all United States stocks is 59.32% higher than that of the company.
Polarean Imaging plc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Polarean Imaging's current stock value. Our valuation model uses many indicators to compare Polarean Imaging value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Polarean Imaging competition to find correlations between indicators driving Polarean Imaging's intrinsic value. More Info.Polarean Imaging plc is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Polarean Imaging's earnings, one of the primary drivers of an investment's value.About Polarean Imaging Financial Statements
Polarean Imaging stakeholders use historical fundamental indicators, such as Polarean Imaging's revenue or net income, to determine how well the company is positioned to perform in the future. Although Polarean Imaging investors may analyze each financial statement separately, they are all interrelated. For example, changes in Polarean Imaging's assets and liabilities are reflected in the revenues and expenses on Polarean Imaging's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Polarean Imaging plc. Please read more on our technical analysis and fundamental analysis pages.
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina. Polarean Imaging operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Polarean Pink Sheet
Polarean Imaging financial ratios help investors to determine whether Polarean Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Polarean with respect to the benefits of owning Polarean Imaging security.